The REMOVAL study is a unique multi‐centre, double‐blind, randomised, placebo‐controlled trial that studied the cardiovascular and metabolic effects of metformin as an adjunct to insulin therapy in 493 patients with T1D over 3 years.61 Here, INS is linked to type 1 diabetes mellitus.